Dr. Delitto Awarded NCI R37
May 7, 2026
Dr. Dan Delitto has received an R37 MERIT Award from the National Cancer Institute (NCI) for his research project, "Reprogramming inflammatory fibroblasts to overcome therapeutic resistance in pancreatic adenocarcinoma PDAC."
"Pancreatic ductal adenocarcinoma is one of the deadliest cancers because it becomes surrounded by dense scar tissue that protects tumors from treatment and prevents the immune system from mounting an effective attack," said Delitto. "This project focuses on a special type of fibroblast within that scar tissue that responds to danger signals, creating intense inflammatory 'noise' that disrupts the body’s natural anticancer immune response."
PDAC is the most common form of pancreatic cancer, accounting for 90% of cases. In 2024, the 5-year overall survival rate for PDAC is under 10.8% for both metastatic and resectable cases. It is projected to become the second-leading cause of cancer deaths by 2030.
"By understanding how these fibroblasts develop and how they suppress antitumor T cells, this research aims to develop a new treatment strategy that restores immune function and improves the effectiveness of immunotherapy," said Delitto. "The long-term goal is to transform the tumor environment from one that shields cancer into one that enables the immune system to fight back more effectively."
According to their website, the NCI is using the MERIT Award "to provide longer-term grant support to Early Stage Investigators. The objective of the NCI's MERIT Award is to allow eligible investigators the opportunity to obtain up to seven years of support in two segments."
Related Stories
- – Surgery
Exploring the Intersection of Surgery and Cancer Research with Dr. Dan Delitto
Dr. Dan Delitto is an assistant professor of surgery at Stanford University specializes in surgical oncology and holds a PhD in immunology. On this episode, Dr. Delitto reflects on his decision to pursue an MD-PhD pathway during residency and discusses the recent advancements in single-cell RNA sequencing technology that his lab has acquired. He explains the complex role of fibroblasts in cancer development, particularly in pancreatic ductal carcinoma, highlighting how these cells can both promote and hinder tumor growth.
- – Surgery
Dr. Delitto Receives Damon Runyon Clinical Investigator Award
Dr. Dan Delitto has received the Damon Runyon Clinical Investigator Award. Dr. Delitto will receive $600,000 over the course of three years to pursue novel immunotherapeutic approaches to fibrotic tumors, particularly pancreatic cancer.
Media Contact
Bio
About Stanford Surgery
The Stanford University Department of Surgery is dedicated to inventing the future of surgical care through:
• pioneering cutting-edge research,
• developing the next generation of leaders, and
• healing through incomparable surgical skills and compassion.
To learn more, please visit surgery.stanford.edu
The Latest
- Surgery
INSIDE: Holman26
Stanford Surgery's annual celebration of science, Holman Day, took place on Friday, June 5, 2026 with Dr. Ginny Bumgardner as the keynote lecturer.
- ACS
Sustainable Training Strengthens Kidney Transplant Capacity in Resource-Limited Systems
Hands-on partnerships enable surgeons to develop sustainable transplant programs that address disparities in low-income countries. Drs. K. Thomas Pham and Tyler York are featured.
- PedsTalks Podcasts for Physicians
Correction Without Compromise: What Every Pediatric Provider Should Know About Chest Wall Defects
Drs. Stephanie Chao and Marisa Schwab, MD star on this epsiode of PedsTalks about Chest Wall Defects.
- Surgery
Robotic Surgery: From Training to Innovation with Dr. Aaron Dawes
Dr. Aaron Dawes discusses his work as Stanford's Director of Robotic Education, where he's transforming the curriculum. He also shares insights on performing California's first single-port colectomy and the future of minimally invasive surgical technology.
- Vascular & Endovascular Surgery
Stanford Vascular Surgery Welcomes Dr. Andres Schanzer as 2026 Al-Khatib Visiting Professor
The Division of Vascular and Endovascular Surgery welcomed Dr. Andres Schanzer as the 2026 Al-Khatib Visiting Professor, continuing a tradition that honors the legacy of Dr. Weesam Al-Khatib and his lasting contributions to Stanford Vascular Surgery.
- Division of Plastic & Reconstructive Surgery
Dr. Stingl Featured in Grey's Anatomy Storyline Inspired by Free Flap Monitoring Innovation
Dr. Cybil Sierra Stingl, a resident in her PD year, was recently featured in an episode of Grey's Anatomy after her work on a wearable free flap monitoring device inspired a storyline in the show’s 22nd season.
- Vascular & Endovascular Surgery
Dr. Nazish Sayed Receives DOD Grant to Study Cardiovascular Effects of Burn Pit Exposure in Veterans
Dr. Nazish Sayed, Associate Professor in the Division of Vascular Surgery at Stanford University, has received a Department of Defense (DOD) Toxic Exposures Research Program (TERP) Translational Research Partnership Award for a project focused on the cardiovascular effects of burn pit exposure in Veterans.
- Division of Plastic & Reconstructive Surgery
Dr. Dennis Shem Appointed Director of Inpatient Dental Medicine and Surgery
Dr. Dennis Shem has been appointed Director of Inpatient Dental Medicine and Surgery at Stanford Health Care, beginning in May 2026.
- Surgery
Dr. Foster Receives SSAT Career Development Award
Dr. Deshka Foster is this year’s recipient of the Society for Surgery of the Alimentary Tract (SSAT) Career Development Award.
- Surgery
Announcing 2026 SIG Leadership
Stanford’s Surgery Interest Group (SIG) announced its four new leaders for the 2026/27 academic year: Brianna Brasko, Rishik Bethi, Rayyan Darji, and Brenda Yu.